Evidence map›Paper›PMID 39765853›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Fullerenol C

Alina A Borisenkova, Mikhail Y Eropkin, Nadezhda I Konovalova, Anna V Titova, Maria A Markova, Zhanna B Lyutova, Anton S Mazur, Victor P Sedov, Vera A Orlova, Anna N Lykholay and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The fullerenol CJournal of bioenergetics and biomembranes · 2026
    Article
  2. Effect of Fullerenol CNanomaterials (Basel, Switzerland) · 2026
    Article
  3. Effect of Fullerenol CMolecules (Basel, Switzerland) · 2025
    Article
  4. Evaluation of Immunotoxicity of Fullerenol CBulletin of experimental biology and medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alina A BorisenkovaRadiation Technology Department, St. Petersburg State Institute of Technology, Technical University, 190013 St. Petersburg, Russia.ORCID 0000-0002-7618-5617
Mikhail Y EropkinSmorodintsev Research Institute of Influenza, 197022 St. Petersburg, Russia.ORCID 0000-0002-3306-847X
Nadezhda I KonovalovaSmorodintsev Research Institute of Influenza, 197022 St. Petersburg, Russia.
Anna V TitovaRadiation Technology Department, St. Petersburg State Institute of Technology, Technical University, 190013 St. Petersburg, Russia.
Maria A MarkovaRadiation Technology Department, St. Petersburg State Institute of Technology, Technical University, 190013 St. Petersburg, Russia.
Zhanna B LyutovaRadiation Technology Department, St. Petersburg State Institute of Technology, Technical University, 190013 St. Petersburg, Russia.
Anton S MazurResearch Resource Center "Magnetic Resonance Research Methods", St. Petersburg State University, 199034 St. Petersburg, Russia.
Victor P SedovPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", 188300 Gatchina, Russia.
Vera A OrlovaKhlopin Radium Institute, 194021 St. Petersburg, Russia.
Anna N LykholayResearch Resource Center "Molecular and Cell Technologies", St. Petersburg State University, 199034 St. Petersburg, Russia.
Diana N OrlovaPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", 188300 Gatchina, Russia.
Alexandr V ArutyunyanPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", 188300 Gatchina, Russia.ORCID 0000-0002-2310-1686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections and many other dangerous diseases are accompanied by the development of oxidative stress, which is a consequence of an increase in the level of the reactive oxygen species (ROS). In this regard, the search for effective antioxidants remains highly relevant. We tested fullerenol C

Indexed as

anti-influenza activityantioxidant scavenging activitybiocompatibilitycytoprotectionfullerenolphysicochemical characterizationreactive oxygen speciesself-assemblytoxicity

Identifiers

PMID39765853
PMCPMC11727559

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.